WAYNE, Pa., Oct. 23, 2024 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the launch of two new devices in Canada designed to enhance PICC insertion procedures and reduce the chance of complications. The next-generation Arrow™ VPS Rhythm™ DLX Device and NaviCurve™ Stylet are engineered to work together to give Vascular Access professionals more efficient and predictable PICC placement.
Tag: PICC
Dynamic Access Acquires Priority PICC Solutions in Chicago
DALLAS, July 25, 2023 /PRNewswire/ — Dynamic Access, LLC (Dynamic), a leading provider of outsourced vascular access services, has announced the acquisition of Priority PICC Solutions, LLC (Priority) based in Chicago, Illinois. Priority has been providing expert services to healthcare facilities in Chicago and surrounding areas since […]
Access Vascular Inc. Announces Publication of Study Showing Significantly Reduced Failure Rates with its HydroPICC® Catheter
BILLERICA, Mass.–(BUSINESS WIRE)– Access Vascular, Inc. (AVI), a medical device company addressing the most common and costly complications of intravenous therapy, today announced the publication of a peer-reviewed study of its HydroPICC® peripherally inserted central catheter (PICC) in the journal Journal of Materials Science: […]
Access Vascular Receives FDA Clearance For Its HydroPICC Catheter
BEDFORD, Mass., Feb. 22, 2018 /PRNewswire/ — Access Vascular, a medical device company reinventing venous access using proprietary material technology designed to reduce thrombus accumulation, announced today that the Company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for […]
SecurAcath Receives NICE Recommendation: Highlights Massive Cost Savings from Improved Catheter Securement
PLYMOUTH, Minn.–(BUSINESS WIRE)–Interrad Medical, a privately held medical device company, announces the SecurAcath Subcutaneous Engineered Stabilization Device is now recommended by the National Institute for Health and Care Excellence (NICE). The SecurAcath underwent a detailed assessment under the Medical Technologies […]